Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website .
The distinction between benign leiomyomata (fibroids) and smooth muscle sarcomas in the uterus is clear. 1 The genetic changes in sarcomas are more complex than in fibroids [many references over 20 years, available on request]. Interestingly, the specific genetic aberration detected may vary from cell to cell suggesting a high level of genomic instability. This instability can also be detected by techniques that measure allelic imbalance such as comparative genomic hybridization, and is not present in benign fibroids. 2 Some changes are unique to sarcomas such as a heterozygosity for the long arms of chromosomes 10 and 13 that is found in more than half of sarcomas.